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Background: Sichuan Province is an agricultural and economically developing province in western China.
To understand practices of prescribing medications for outpatients in rural township health centers is important
for the development of the rural medical and health services in this province and western China.
Methods: This is an observational study based on data from the 4th National Health Services Survey of China.
A total of 3,059 prescriptions from 30 township health centers in Sichuan Province were collected and analyzed.
Seven indicators were employed in the analyses to characterize the prescription practices. They are disease
distribution, average cost per encounter, number of medications per encounter, percentage of encounters with
antibiotics, percentage of encounters with glucocorticoids, percentage of encounters with combined
glucocorticoids and antibiotics, and percentage of encounters with injections.
Results: The average medication cost per encounter was 16.30 Yuan ($2.59). About 60% of the prescriptions
contained Chinese patent medicine (CPM), and almost all prescriptions (98.07%) contained western medicine.
85.18% of the prescriptions contained antibiotics, of which, 24.98% contained two or more types of antibiotics; the
percentage of prescriptions with glucocorticoids was 19.99%; the percentage of prescriptions with both
glucocorticoids and antibiotics was 16.67%; 51.40% of the prescriptions included injections, of which, 39.90%
included two or more injections.
Conclusions: The findings from this study demonstrated irrational medication uses of antibiotics, glucocorticoids
and injections prescribed for outpatients in the rural township health centers in Sichuan Province. The reasons for
irrational medication uses are not only solely due to the pursuit of maximizing benefits in the township health
centers, but also more likely attributable to the lack of medical knowledge of rational medication uses among rural
doctors and the lack of medical devices for disease diagnosis in those township health centers. The policy
implication from this study is to enhance professional training in rational medication uses for rural doctors, improve
hardware facilities for township health centers, promote health education to rural residents and establish a public
reporting system to monitor prescription practices in rural township health centers, etc.Background
With rapid development and reform of the health services
system, the focus of medication utilization in China has
gradually changed from improving the accessibility of
medications to the rational use of medications, namely, to
use medications safely, effectively and economically [1].
Prescribing medication rationally is playing a key role in* Correspondence: juying109@163.com
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reproduction in any medium, provided the orreducing the health care burden and improving health
conditions of the general population in China.
Since the founding of the People’s Republic of China
in 1949, public health prevention and health care ser-
vices have been organized around a three-tier health
care delivery system. In urban areas, the three-tier net-
work is composed of community health service centers,
district hospitals, and city hospitals. In rural areas, it
consists of village clinics, township health centers
(THCs), and county hospitals. The basic features of this
system have remained the same to date [2]. Since thetd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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network, their missions are (a) to provide basic medical
and public health services for the local population, (b) to
provide technical training for local health workers, and
(c) to provide technical guidance to the village clinics. In
2001, a new policy, titled “The Guidelines on Rural
Health Sector Reform and Development” and promul-
gated by the central government (State Council 2001),
emphasized that each township should have the owner-
ship of one health center supported by the local govern-
ment. This policy gives the THCs government-owned
status with responsibility of providing basic health services
for hundreds of millions of rural residents. The THCs play
an important role in the national health services system
for controlling infectious diseases, improving the quality
of health services and guaranteeing people’s health in rural
areas of China, and were regarded as one of the “three
magic weapons (Rural Cooperative Medical Schemes,
barefoot doctors and township health centers)” of the rural
health services of China by WHO [3].
The 4th National Health Services Survey (NHSS,
2008) was conducted when a new round of medical and
health system reform was launched. The main purpose
of this survey is to provide baseline information for the
implementation and assessment of the new round of
medical and health system reform of the past five years,
and to provide evidence for the "Healthy China 2020"
plan in terms of objectives, targets and major actions
[4]. Understanding the outpatient medication prescrip-
tion practice in the primary health care institutions is
important to guide the rational use of medications, to
reduce the cost of the prescriptions, and to support
evidence-based health care reform and policy develop-
ment for both local and central governments. Therefore,
the Ministry of Health of China (MoH) conducted the
Outpatient Prescription Survey, as an additional part of
the 4th NHSS in 2008.
Since China launched the strategy of “Developing the
Western Region” in 2000 (covering 380 million people
in 12 provinces), the central government has given vig-
orous supports to the development of medical and
health service in the economically depressed western re-
gion. Up to 2010, the central government had invested
78.62 billion Yuan ($12.48 billion, 1 USD = 6.30 RMB
Yuan) in total to 12 western provinces, which accounted
for 43.3% of the whole national medical service budget
of 181.40 billion Yuan ($28.79 billion) [5]. That means,
the health expenditures per capita devoted by the central
government in western China was about 206.9 Yuan
($32.8) in the past 10 years. Sichuan is a typical agricul-
tural province with a large population in the western re-
gion. By the end of 2008, there were 50.944 million rural
residents, 181 counties (or cities or districts), 4544 towns
and 4803 THCs in Sichuan. Therefore, it is of greatimportance to investigate the medical prescription prac-
tice in the THCs of this province to inform the develop-
ment and reform of the rural health service system in
western China.
The aims of this study are to (a) describe outpatient
prescription practices in the rural THCs in Sichuan
Province, (b) assess any irrational malpractice in medical
prescriptions and (c) explore the possible reasons and
provide some suggestions for solving the problems in
rural medical prescription practice.
Methods
Data source
The data used in this study came from the Outpatient
Prescription Survey of the THCs in Sichuan Province,
which was a part of the 4th National Health Services
Survey (NHSS) of China in 2008.
Using a three-stage probability proportion to size sam-
pling method, the NHSS randomly selected 30 counties
in Sichuan Province in the first stage, one town from
each sampled counties in the second stage, and one
THC from each sampled town in the third stage for the
Prescription Survey. To sample outpatient prescriptions,
the systematic random sampling method was used to se-
lect 25 outpatient prescriptions on 17th September and
18th December of 2007, and 19th March and 20th June
of 2008, respectively. If the total number of the prescrip-
tions was less than 25 on a sampling day, the sampling
would continue on the next day and so on until the
number of prescriptions reached 25. Excluded from the
sample unit were the prescriptions of emergency, infec-
tion, surgery and traditional Chinese medicine decoction
pieces (prepared Chinese herbal medicine in small pieces
ready for decoction, and medicine materials in crude
slices), as well as laboratory test reports.
The 4th NHSS was designed by an expert panel from
the Center for Statistics Information, MoH of China, and
was composed of four sub-surveys: the Household Health
Survey, the Health Institution Survey, the Prescription
Survey and the Medical Staff Survey. All four sub-surveys
were implemented in the same city/town/district at the
same time. The three-stage probability proportion to size
sampling method was adopted to ensure that about 1% of
the population in each sampling province be included in
the Household Health Survey, and that a sufficient sample
size be obtained in the Health Institution Survey and the
Prescription Survey. Prior to the formal survey, a pilot
study was conducted by the MoH of China. Results of the
pilot study showed that the average number of daily out-
patient prescriptions among the THCs was about 25 per
day. Statistical experts from the Center for Statistics Infor-
mation estimated that 100 prescriptions sampled from
each THC would be sufficient to represent the basic an-
nual prescription practice of the THC. The selected four
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sons: spring, summer, autumn and winter respectively.
These dates also represented one day of a week, excluding
weekends, statutory holidays and other special days. In
short, this sampling method was aimed at adequate sam-
ple size and the representativeness of the sample.
Questionnaires of the Prescription Survey were designed
by the expert panel from the Center for Statistics Informa-
tion, MoH. The county or district or city level health bur-
eaus were responsible for administrating survey training,
data collection and quality checking of the questionnaires.
It was mandatory that each sampled county (or district or
city) set up a Quality Assessment Team to check the qual-
ity of the survey in the data collection process, and that 5%
of the questionnaires was randomly selected for review
after the completion of the survey. In addition, the MoH
assigned a group of experts to supervise the survey. The
Center for Statistical Information developed the software
for data entry and management. Double data entry and val-
idation procedures were adopted to minimize human
errors in data entry. The data checking that occurred in
each sampled county (or district or city) was strictly moni-
tored by the designated persons in the provinces.
Since the NHSS is a national survey organized by the
MoH, all health institutions and individuals involved had
responsibilities and obligations to cooperate with the
investigators. The 4th NHSS was approved by the ethics
committees of the Center for Statistics Information, MoH.
In addition, the Prescription Survey was completely an-
onymous, and fully took human rights and ethical issues
into consideration when it was designed, so the prescribers
would not care whether they were being monitored at all.
The Contract units, such as Sichuan Health Information
Centre and Sichuan University, were only responsible for
data collection and analysis.
Analysis
Contents of the Prescription Survey included: distribu-
tion of different disease diagnoses, costs of prescriptions,
and utilization practices (numbers and types) of different
medications. Seven indicators were used for description
in this study: (1) Distributions of the top 10 common
diseases; (2) Average cost per encounter; (3) Average
number of medications per encounter; (4) Percentage of
encounters with antibiotics prescribed; (5) Percentage of
encounters with glucocorticoids prescribed; (6) Percent-
age of encounters with combined glucocorticoids and
antibiotics prescribed; (7) Percentage of encounters with
injections prescribed. Among the above indicators, (2),
(3), (4), (5) and (7) are WHO standard indicators [6].
The definitions of ‘antibiotic’, ‘glucocorticoid’ and ‘injec-
tion’ in this article are consistent with the standard defini-
tions of the 4th NHSS. ‘Antibiotic’ refers to synthetic
antibacterial medications and antimicrobial agents of non-plant components including penicillin and medications of
other anti-bacterial, anti-skin infection, anti-ophthalmic
infection and anti-diarrhoeal that contain gentamicin, qui-
nolones or other compounds. Medications of anti-filariasis,
anti-leprosy, anti-TB, anti-fungal and anti-malarial were
not defined as ‘antibiotics’. ‘Glucocorticoid’ refers to sys-
temic glucocorticoids, excluding local glucocorticoids, such
as those applied topically. ‘Injection’ is exclusive of vaccin-
ation, solvent, systemic or local anesthesia, or subconjunc-
tival and retrobulbar injection.
Results
Final data available for the analysis in this study consist
of 3059 prescriptions from 30 rural THCs in Sichuan
Province.
Distributions of diseases
In Table 1, we list the top 10 common diseases accord-
ing to the frequency of their prescriptions. It is clearly
shown that the majority of diagnoses were in the cat-
egories of respiratory and digestive system diseases.
Upper respiratory tract infection (URTI), gastroenteritis,
common cold, chronic obstructive pulmonary disease
(COPD) and female genital disease were at the top five
diagnoses. Hypertension was ranked tenth among the
most common prescribed diseases.
Average cost per prescription
The median cost per encounter was 16.30 Yuan ($2.59).
Among the prescriptions for the top 10 common dis-
eases, the highest median cost was for pneumonia and
female genital diseases, 31.50 Yuan ($5.00) and 30.55
Yuan ($4.85), respectively as shown in Table 1.
Utilization of Chinese patent medicine
Chinese patent medicine (CPM) also known as Zhongcheng
Yao in Chinese. "Patent" refers to the standardization
of the formula. Specifically, CPM uses traditional
medicine and herb drugs as raw materials and pro-
cesses those raw materials into certain dosage forms
according to the prescription book and refining
method. Patents may come in the forms such as tea-
pills, dripping pills, liquids, syrups, powders, granules,
instant teas, and capsules. In China, many of CPMs
have been well-known and widely used, due to their
features of curative effect, convenience and inexpensive-
ness. They are often used when a patient's condition is
not severe or urgent and the medicine can be taken as
a long-term treatment. So the utilization of CPM was
included in the Prescription Survey of the 4th NHSS.
Close to 60% of the prescriptions contained CPM, and
the median number of CPM per prescription was one.
Approximately 20% of the prescriptions contained two
or more CPMs (see Table 2). 94.00% of the prescriptions
Table 1 Proportion and average cost of the top 10 common disease prescriptions








1 Upper respiratory tract infection 652 (21.31%) 13.00 2.06 0.40 - 147.00 0.06 - 23.33
2 Gastroenteritis 344 (11.25%) 16.35 2.59 0.60 - 204.40 0.10 - 32.44
3 The common cold 272 (8.89%) 10.00 1.59 0.80 - 119.00 0.13 - 18.89
4 COPD 198 (6.47%) 18.90 3.00 1.20 - 184.00 0.19 - 29.20
5 Female genital diseases 148 (4.84%) 30.55 4.85 1.00 - 138.40 0.16 - 21.97
6 Pneumonia 86 (2.81%) 31.50 5.00 2.50 - 194.30 0.40 - 30.84
7 Rheumatoid arthritis 80 (2.62%) 17.40 2.76 1.70 - 156.00 0.27 - 24.76
8 Other digestive tract diseases 73 (2.39%) 10.00 1.59 1.00 - 106.15 0.16 - 16.85
9 Dental diseases 63 (2.06%) 14.00 2.22 1.00 - 144.00 0.16 - 22.85
10 Hypertension 61 (1.99%) 20.70 3.29 4.00 - 215.30 0.63 - 34.17
a1 USD = 6.3009 RMB Yuan.
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among the top 10 common diseases (see Table 3).
Utilization of western medicine
Almost all prescriptions (98.07%) contained western medi-
cine, and the median number of western medicines per
encounter was four. 36.64% of the prescriptions contained
1–3 western medicines. Close to half (43.42%) of the pre-
scriptions contained 4–5 western medicines. Almost one
fifth (18.01%) of the prescriptions contained six or more
western medicines (see Table 2). Among the top 10 com-
mon diseases, 43.02% of pneumonia prescriptions con-
tained six or more western medicines (see Table 3).
Utilization of antibiotics
The majority (85.18%) of the prescriptions contained anti-
biotics, and the median number of antibiotics per encoun-
ter was one. A quarter (24.98%) of the prescriptions
contained two or more antibiotics. In detail, prescriptions
with two, three, four or more antibiotics comprised re-
spectively 19.88%, 3.78% and 1.32% of the total. Almost all
(96.86%) of the COPD prescriptions contained antibiotics,
which was the highest among the top 10 common diseases,
followed by pneumonia (95.12%) and female genital dis-
eases (94.33%). About a half (48.23%) of the prescriptions
for female genital diseases and 35.37% of the prescriptions
for pneumonia contained two or more antibiotics. Finally,
the proportions of the prescriptions with three or more
antibiotics for female genital diseases, dental diseases and
pneumonia were all above 8% (see Table 4).Table 2 Proportion of prescriptions containing CPM and west
Type of the medications Number of
0 1-3
Chinese patent medicine 43.84 55.54
Western medicine 1.93 36.64
Total 0.29 21.74Utilization of glucocorticoids
About 20% of prescriptions contained any glucocorticoids.
Among the top 10 common diseases, the highest propor-
tions of prescriptions with glucocorticoids were for
rheumatoid arthritis (42.86%), COPD (32.61%) and pneu-
monia (30.86%), which were much higher than other dis-
eases. Surprisingly, 28.36% of common cold (flu), 23.73%
of dental disease, and 10.14% of female genital diseases
were also prescribed glucocorticoids (see Table 4).
Utilization of combined glucocorticoids and antibiotics
In total, 16.67% of the prescriptions contained both gluco-
corticoids and antibiotics. Among the top 10 common dis-
eases, the highest proportion of prescriptions combined
the two was given to the diagnoses of COPD (30.30%),
pneumonia (27.91%) and rheumatoid arthritis (25.00%)
(see Table 4).
Utilization of injections
Over half (51.40%) of the prescriptions contained injec-
tions. The median number of injection prescribed per en-
counter was one. The prescriptions that included two or
more injections consisted of 39.90% in total, with 14.19%,
9.91% and 15.80% of two, three, four or more injections
respectively. Particularly, the proportion of prescriptions
containing injections was 74.24% for pneumonia and
66.87% for COPD, higher than that for other diseases.
Such high rates of injections used for the two diseases
were also reflected by the high proportion of prescriptions
that contained two or more injections, 63.64% forern medicine (%)





Table 3 Proportion of prescriptions with CPM and western medicine of the top 10 common diseases (%)
Rank Diagnoses Number of Chinese patent medicine Number of western medicine
0 1 2 3 4 ≥5 0 1 2 3 4 5 ≥6
1 Upper respiratory tract infection 23.34 45.35 26.00 4.74 0.19 0.38 0.15 3.24 8.47 24.81 25.73 21.11 16.49
2 Gastroenteritis 32.43 45.56 19.31 1.93 0.39 0.39 0.00 2.92 7.02 23.98 28.65 21.35 16.08
3 The common cold 18.64 57.27 18.64 4.55 0.00 0.91 1.18 2.76 11.81 22.05 23.62 24.02 14.57
4 COPD 20.75 53.46 23.27 2.52 0.00 0.00 0.00 2.02 6.06 18.69 25.25 22.73 25.26
5 Female genital diseases 25.00 43.52 23.15 7.41 0.93 0.00 0.68 7.53 13.70 18.49 21.23 17.81 20.55
6 Pneumonia 17.14 55.71 18.57 4.29 2.86 1.43 1.16 1.16 3.49 12.79 18.60 19.77 43.02
7 Rheumatoid arthritis 21.82 50.91 25.45 1.82 0.00 0.00 1.25 5.00 8.75 16.25 30.00 23.75 15.00
8 Other digestive tract diseases 42.59 42.59 12.96 0.00 0.00 1.85 2.74 4.11 20.55 20.55 23.29 12.33 16.44
9 Dental diseases 28.85 46.15 23.08 1.92 0.00 0.00 0.00 7.94 12.70 25.40 19.05 17.46 17.46
10 Hypertension 6.00 62.00 30.00 2.00 0.00 0.00 0.00 9.84 14.75 32.79 11.48 9.84 21.31
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40% of the prescriptions for female genital diseases, dental
diseases and other digestive tract diseases contained two
or more injections. Prescriptions with four or more injec-
tions were also observed among all the top 10 common
diseases, with the highest three proportions of 42.42%,
28.75% and 28.75% for pneumonia, COPD and hyperten-
sion respectively (see Table 4).
The polypharmacy practice in the THCs
The prescriptions with 1–3, 4–5 and six or more medi-
cations (western medicine or Chinese patent medicine
or both) comprised respectively 21.74%, 46.68% and
31.29% of the total (see Table 2). The median number of
medications per encounter was four.
The median number of western medicines prescribed
per encounter distributed differently among the surveyed
30 THCs. The median number of western medicine pre-
scribed among the 30 surveyed THCs varied from two to






2 3 ≥4 total
1 Upper respiratory tract
infection
92.52 17.52 2.07 0.96 20.55
2 Gastroenteritis 86.20 19.63 4.60 1.84 26.07
3 The common cold 82.68 13.42 0.43 0.00 13.85
4 COPD 96.86 25.13 4.71 1.05 30.89
5 Female genital diseases 94.33 39.01 9.22 0.00 48.23
6 Pneumonia 95.12 26.83 6.10 2.44 35.37
7 Rheumatoid arthritis 72.86 12.86 4.29 0.00 17.15
8 Other digestive tract
diseases
80.30 22.73 1.52 3.03 27.28
9 Dental diseases 91.94 17.74 8.06 1.61 27.41
10 Hypertension 43.75 2.08 4.17 0.00 6.25not seen in the CPM prescriptions among the surveyed
THCs. A greater proportion of surveyed THCs (73%, or
22 out of 30 THCs) prescribed four or more western med-
ications per encounter versus only a few (13%, or 4 out of
30 THCs) which prescribed two or more CPMs per en-
counter (see Figure 1).
Discussion and conclusion
The WHO recommended that the average number of
medications (refers to western medicines only) per en-
counter for outpatients should be 1.6 to 2.8 in developing
countries [7]. In 2007, the Prescription Administrative
Policy of China (MoH, 2007) specified that the average
number of medications (refers to western medicines, or
CPMs, or both) per encounter must be less than 6 [8]
based on the reviewed results that when the number of
medications per encounter was less than 6, 6–10, 11–15
and 16–20, the incidence of adverse reactions was 4%,
10%, 28% and 54%, respectively [9]. The average number







2 3 ≥4 total
21.47 19.94 53.37 17.15 8.48 12.33 37.96
5.28 4.94 38.78 8.98 6.53 13.06 28.57
28.36 18.75 43.75 18.18 8.52 7.39 34.09
32.61 30.30 66.87 13.13 15.00 28.75 56.88
10.14 9.46 52.94 17.65 11.76 12.75 42.16
30.86 27.91 74.24 10.61 10.61 42.42 63.64
42.86 25.00 32.08 5.66 3.77 11.32 20.75
2.86 2.74 52.83 18.87 9.43 11.32 39.62
23.73 20.63 44.68 17.02 10.64 12.77 40.43

































Code of Surveyed THCs
Chinese Patent Medicine Western Medicine
Figure 1 Distribution of median number of medications per prescription among the 30 THCs.
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ard, but notably higher than the WHO recommended
standard. However, other developing countries, such as
Pakistan, also reported slightly higher number of medica-
tions (average of four per encounter) prescribed by med-
ical practitioners [10]. Our study found that (a) more than
60% of the prescriptions did not follow the WHO recom-
mended standard by prescribing four or more western
medications; (b) more than 18% of the prescriptions did
not even follow the Prescription Administrative Policy of
China by prescribing six or more western medicines per en-
counter; and (c) the problem of over-prescribing western
medications in the treatment of pneumonia was most
prominent among the top 10 common diseases. Over 40%
of pneumonia prescriptions had six or more western
medicines.
Most clinical bacterial infections can be controlled with
one antibiotic. It remains controversial whether combin-
ation antimicrobial therapy is more efficacious than mono-
therapy [11,12]. Nevertheless, there was wide consensus
that the number of antibiotics per encounter should be
controlled within two or three [13-15]. The indications for
combination antimicrobial therapy only include: (a) empir-
ical treatment of life-threatening infections; (b) treatment
of polymicrobial infections; (c) prevention of the emer-
gence of bacterial resistance; and (d) for synergism [11,16].
Otherwise, any unnecessary usage of multiple antibiotics
will give rise to side effects, drug resistance, high cost and
other problems [13-15]. According to a WHO report based
on prescription data of 11 Asian and African countries
(2002), the proportion of prescriptions with antibiotics ran-
ged from 27% to 63%, with the noticeable low figures of
20.0%-26.8% from developing countries. However, the
overall proportion of antibiotics prescription among the
THCs in Sichuan was 85.18%, considerably exceeding the
WHO recommendation of ‘not more than 30%’ and ofthe national recommendation of ‘below 50%’ proposed
by the ‘Regulations on Hospital Infection Administration
of China’ [17]. The proportion of prescriptions with two
or more antibiotics in this study was 24.98%, much
higher than the previously reported national average
(15.7%) in the same year [18].
There are strict restrictions on the use of glucocorti-
coids. Long-term use of large doses of glucocorticoids can
cause central obesity, hypertension, hyperglycemia and
other adverse consequences [19,20]. The Chinese national
reference level of using glucocorticoids ranged from 0% to
9.95% [1]. This study revealed a much higher level of glu-
cocorticoids utilizations in the THCs of Sichuan, 19.99%
in general, 42.86% for rheumatoid arthritis, 32.61% for
COPD and 30.86% for pneumonia, and 10.14%-28.36% for
other top 10 common diseases. This result suggests that
the Administrative Department of Health of Sichuan pro-
vincial government should pay more attention to the un-
necessary use of glucocorticoids in the THCs and develop
certain policy on glucocorticoids utilization at all levels of
health care providers.
A novel finding of our study was the significantly high
utilization of combined antibiotics and glucocorticoids at
the THCs in Sichuan Province. Some studies showed that
the irrational use of combined antibiotics and glucocorti-
coids can lead to the spread of bacterial infection and in-
duce other new infections [21]. This has recently become
a new focus of pharmacy research in China. It has been
accepted that only certain severe infections require the
combined use of glucocorticoids and antibiotics. For ex-
ample, the combined use of oral antibiotics and systemic
corticosteroids decrease the risk of deterioration for acute
exacerbations of COPD [22]. By examining the details of
the combined use of antibiotics and glucocorticoids in
THCs in Sichuan Province, this study revealed that there
was unnecessary and irrational co-prescribing of antibiotics
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example, even in the prescription for URTI and common
cold, which did not need to take antibiotics and glucocorti-
coids together, yet nearly 20% of the prescriptions con-
tained both glucocorticoids and antibiotics. We have not
found any publication discussing the combinatorial usage
of antibiotics and glucocorticoids with exact proportions in
western China before.
Injections are the most frequent medical procedure per-
formed throughout the world. About 16 billion injections
are administered each year in developing and transitional
countries [23]. Overuse of injection not only increases the
health care costs, but also increases potential spread of iat-
rogenic diseases and affects the quality of clinical care
[24,25]. According to the WHO recommendation for the
rational use of medications for outpatients in the develop-
ing countries, the optimal proportion of injection should
be 13.4% - 24.1% of total prescriptions [3]. The proportion
of prescriptions with injections in the THCs in Sichuan
was 51.40%, far exceeding the WHO standard. Worse than
that, the proportion of using multiple injections in one
prescription was as high as 39.90% overall. Specifically, the
proportion of prescriptions with four or more injections
for treating pneumonia, COPD and hypertension was as
high as 42.42%, 28.75% and 16.28% respectively. These
results reveal that the overuse of injections, particularly
the excessive unrestricted use of multiple injections, has
become a big problem at the rural healthcare facilities in
Sichuan. This overuse of injection phenomenon was also
reported in other developing countries in recent years,
such as in Cambodia, India and Pakistan [26-30]. Some
scholars speculated that the abuse of injections was inex-
tricably linked to the medical consumption concept of the
consumers [26,31]. There is still a popular belief in China
that injections are more convenient and effective than oral
medications. Since few people know about the pernicious
consequences of injection abuse, it is very common that
patients demand injection treatments for the purpose of
quick recovery from sickness. On the other hand, from
the doctors’ perspective, injections are not only making
their patients satisfied, but also producing more revenues
for the health care facilities and themselves [31]. The
Department of Health of provincial and local governments
should make special efforts to enhance health education
on the rational use of injections for the general population,
and develop more targeted policy and program manage-
ment for prescription practice at rural health care facilities.
Public health education can promote general knowledge
on the potential dangers of irrational use of medical injec-
tions, with a goal of changing the conventional consumer
attitudes.
In summary, these results discussed above indicate
that the irrational use of medications or polypharmacy is
a major problem in the rural THCs in Sichuan. InChina, health centers in rural areas in general have
poorer resources than district or city health facilities,
and are hence less likely to attract doctors with higher
degrees or better experiences [1]. This evidence suggests
some possible causes of irrational use of medications: (a)
the rural medical institutions’ pursuit of maximizing
economic profits, (b) the lack of medical skills and
knowledge of rational medical prescriptions among rural
doctors, (c) the lack of basic medical devices for diagno-
sis which leads to polypharmacy to cover ambiguous
diagnoses, and (d) a lack of guidelines and effective pol-
icy for rational medical prescription practice in primary
health care institutions. The median cost per encounter in
THCs in Sichuan was 16.30 Yuan ($2.59) in 2008, signifi-
cantly lower than that of the national average 24.84 Yuan
($3.94) in the same period [18]. This suggests that the ir-
rational prescription practice in Sichuan is not pursuing
economic profits, but the non-competency (lack of medical
skills and knowledge) of doctors and/or ambiguous or un-
certain clinical diagnosis due to lack of functional medical
diagnosis equipment. According to the data from the Facil-
ities Survey of the 4th NHSS of China (2008), in Sichuan
Province, a large proportion of the health professionals in
rural areas had relatively low education and low profes-
sional quality. Almost half (49.4%) of them had only tech-
nical secondary school education (which is equivalent to a
high school) [32]. The average number of medical practi-
tioners in the THCs was lower than the national average
(4 vs. 6), and the average number of assistant medical prac-
titioners in the THCs was also lower than the national
average (3 vs. 4) [18,32]. Meanwhile, a considerable
amount of the rural THCs in Sichuan still lacked basic
functional diagnostic equipment. Only 24.1% of the THCs
were equipped with automatic biochemical analyzers, and
27.6% of them had spectrophotometers [32].
Furthermore, we analyzed the median number of CPM
and western medicine prescribed per encounter among
the 30 sampled THCs. The results showed a more evenly
distributed median number of CPM per encounter, com-
pared to the uneven distribution of the median numbers
of western medicine prescribed per encounter among the
THCs. This means the prescription practice for western
medicine was not administered in the same pattern among
these THCs. Particularly, a greater proportion of surveyed
THCs (73%, or 22 out of 30 THC) prescribed four or more
western medications per encounter. Thus, we speculate
that the irrational prescription practice may also be related
to the lack of quality control on prescription practice in
certain THCs.
These data suggest that apart from taking some mea-
sures to advance the administration system and the regula-
tions for the rational use of medications, the provincial
government must take some effective and practical actions
at the same time, such as providing further education and
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cation) for the rural doctors, and by improving the hard-
ware facilities of the rural THCs to enhance more accurate
clinical diagnoses and to reduce the irrational medication
use. In addition, some Chinese scholars have suggested
establishing a public reporting system to supervise the pre-
scription practices of the doctors [33].
This study also discovered a discrepancy between self-
reported disease prevalence and medication prescription.
Based on the data from the Household Health Survey of
the 4th NHSS of China (2008), in Sichuan Province, the
self-reported two-week prevalence of hypertension was
10.0‰ and the self-reported chronic hypertension was
28.0‰ among the rural residents, which were ranked at
6th place and 1st place of all the diseases, respectively,
both ahead of self-reported prevalence of COPD [32].
Nevertheless, this study showed that the number of pre-
scriptions for hypertension ranked only 10th, which was
far behind that of COPD. The results of the Prescription
Survey and the Household Health Survey appeared to be
contradictory to each other. These conflicting results
suggest that many hypertensive patients in rural areas
did not seek treatment, and only a few patients made
outpatient visits. The reasons for this phenomenon may
be as follows: first, a lot of rural patients refuse to have
medical treatment because of the ignorance of their
health, or some of them may just be ignorant about the
risk of hypertension; second, many patients may also
choose self-medication instead of seeing a doctor to save
money, because patients can buy most medications at a
drugstore in China without a prescription from a doctor
[34-36]. Therefore, health education on hypertension pre-
vention and control in rural areas becomes more appar-
ently important, especially with a focus on encouraging
hypertensive patients to seek and comply with medical
treatment. The THCs should strengthen the hypertension
prevention and control program according to the Health
Services Management Criteria for Hypertension (MoH of
China, 2011) [37]. For example, local THCs should carry
out a hypertension screening program yearly, and provide
a face-to-face follow-up treatment for the patients with es-
sential hypertension at least four times a year.
In conclusion, this study revealed certain issues of
prescriptions practice in the THCs of Sichuan. Over-
prescription of western medications (polypharmacy),
antibiotics, injections, and irrational combination use of
antibiotics and glucocorticoids are the major issues.
The reasons for such irrational medication uses are not
for maximizing profits of the THCs, but are more likely
attributable to the lower competency of rural doctors, lack
of medical devices for disease diagnosis in the THCs, lack
of quality control policy and programs on prescription
practice in the THCs, and lack of basic health knowledge
on the adverse side effects of polypharmacy in generalrural populations. Health policy on the quality control of
prescription practice, professional development for rural
doctors, and health education to rural residents could be
essential to enhance prescription practice in the rural
THCs and improve the health conditions of rural residents
in Sichuan Province.
Limitations
There are some limitations in our study. The study is de-
scriptive without in-depth analysis of medications by name
and dosage of specific medicines, and by physical condition
of the patients. This is due to the fact that the Prescription
Survey of the 4th NHSS did not collect such information.
Furthermore, the study also could not provide more infor-
mation and an in-depth discussion about the utilization of
the Chinese patent medicine because of its complex chem-
ical composition— a Chinese patent medicine usually con-
tains several or even dozens of different components, in
one word, it is a complex ‘gray system’ [38].
In the process of administering the Prescription Survey
of the 4th NHSS, the MoH of China and provincial health
bureaus took a series of measures to control the quality of
the survey strictly. However, thousands of prescriptions
were collected and only a small portion of questionnaires
(5% of the total) were checked and reviewed. Therefore,
misstatements or omissions, which we could not predict
and avoid, might exist. Furthermore, we could not collect
prescriptions through the whole year. This may affect the
disease distribution observed in the study because of the
limited survey period. All of these limitations may impact
the results of the survey and our study.
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